SMARCB1 (INI-1) and NUT immunoexpression in a large series of head and neck carcinomas in a Brazilian reference center.
Rodrigo Neves-SilvaLuciana Yamamoto de AlmeidaHeitor Albergoni SilveiraCarla B N ColturatoAndressa DuarteTúlio Morandin FerrisseEvânio Vilela SilvaBárbara F VanzolinAndreia BufalinoAlfredo Ribeiro-SilvaJorge Esquiche LeónPublished in: Head & neck (2019)
The current cases expand the clinicopathological spectrum of SMARCB1 (INI-1)-deficient carcinomas and NUT carcinomas. Notably, the diagnosis of these cases is easily reached through immunohistochemistry, with impact on their accurate classification, treatment, and prognosis.